Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Integrative Genetic and Clinical Analysis through Whole Exome Sequencing in 1001 Diffuse Large B Cell Lymphoma (DLBCL) Patients Reveals Novel Disease Drivers and Risk Groups

Jenny Zhang, Anupama Reddy, Cassandra Love, Andrea B. Moffitt, Deepthi Rajagopalan, Sirpa Leppä, Annika Pasanen, MD PhD, Leo Meriranta, MS, Marja-Liisa Karjalainen-Lindsberg, Peter H Norgaard, MD PhD, Mette Pederson, Anne Ortved Gang, Estrid Hogdall, Kristy L. Richards, PhD MD, Yuri D. Fedoriw, MD, Leon Bernal-Mizrachi, MD, Jean L. Koff, MD, Ashley D. Staton, MD, Christopher Flowers, MDMS, Ora Paltiel-Clarfield, Neta Goldschmidt, MD, Maria Calaminici, Andrew James Clear, John Gribben, Evelyn Nguyen, Magdalena Czader, MD PhD, Sarah Lynn Ondrejka, DO, Angela Collie, MD PhD, Eric D Hsi, MD, Rex au-Yeung, Kwong Yok-Lam, Wai Lap Choi, MD, Gopesh Srivastava, Andrew M Evens, DO, MSc, FACP, Monika Pilichowska, MD PhD, Manju Sengar, Nishitha Reddy, MD MSCI, MBBS, Shaoying Li, MD, Elaine S. Jaffe, MD, Tiffany Tzeng, Jyotishka Datta, David Dunson, Sandeep Dave, MD

Blood (2016) 128 (22): 1087.

https://doi.org/10.1182/blood.V128.22.1087.1087

Published: 2016

Journal Articles

Targeting ß -Catenin Signaling in DLBCL with ICG-001 and PAM-1 Suppresses Cell Proliferation and Induces Apoptosis

Angela A. Fachel, PhD, Ashlesha Shrikant Muley, MS, Cem Meydan, PhD, Xabier Agirre, PhD, Leandro Cerchietti, MD, Ari Melnick, MD, Kristy L. Richards, PhD MD

Blood (2016) 128 (22): 5382.

https://doi.org/10.1182/blood.V128.22.5382.5382

Published: 2016

Journal Articles

Phase III Randomized Study of R-CHOP Versus DA-EPOCH-R and Molecular Analysis of Untreated Diffuse Large B-Cell Lymphoma: CALGB/Alliance 50303

Blood (2016) 128 (22): 469.

https://doi.org/10.1182/blood.V128.22.469.469

Published: 2016

Journal Articles

Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab Following Standard Chemotherapy for Patients with Intermediate-High/High Risk Diffuse Large B-Cell Lymphoma (DLBCL) - Final Results

Nishitha M Reddy, M.B.B.S., David S Morgan, MD, John P Greer, Heidi Chen, Steven I. Park, MD, Kristy L. Richards, PhD MD

Blood (2015) 126 (23): 2739.

https://doi.org/10.1182/blood.V126.23.2739.2739

Published: 2015

Journal Articles

Antiretroviral Therapy Has Equalized Presentations and Short-Term Outcomes Between HIV+ and HIV- Lymphoma Patients in Lilongwe, Malawi

Satish Gopal, Yuri D. Fedoriw, MD, Nathan Montgomery, Agnes Moses, Richard Nyasosela, Yohannie Mlombe, Carlos Varela, Suzgo Mzumara, Maria Chikasema, Salama Itimu, Fred Chimzimu, Coxcilly Kampani, Robert Krysiak, Kristy L. Richards, PhD MD, Thomas C. Shea, MD, George Liomba

Blood (2014) 124 (21): 2626.

https://doi.org/10.1182/blood.V124.21.2626.2626

Published: 2014

Journal Articles

A Phase 2 Trial of Induction Chemotherapy with ABVD Followed By Brentuximab Vedotin Consolidation in Patients with Previously Untreated Non-Bulky Stage I or II Hodgkin Lymphoma

Steven I. Park, MD, Kristy L. Richards, PhD MD, Oludamilola Olajide, MBBS, Nishitha M Reddy, M.B.B.S., Nilanjan Ghosh, MD PhD, Elizabeth E. Budde, MD PhD, Matthew C. Foster, MD, Allison M. Deal, MS, Jeanne F. Noe, PharmD, Thomas C. Shea, MD, Stephen M. Ansell, MD PhD

Blood (2014) 124 (21): 4431.

https://doi.org/10.1182/blood.V124.21.4431.4431

Published: 2014

Journal Articles

Investigation of the Novel Anti-Leukemia Effects of the Marine Compound Pateamine A.

Andrea Dean, MD, Thien Nguyen, Nathan Cox, Matthew Cooper, Kristy L. Richards, PhD, MD, Thomas C. Shea, MD, Nathaniel Moorman, Ph.D, Lee Graves, Ph.D

Blood (2012) 120 (21): 2437.

https://doi.org/10.1182/blood.V120.21.2437.2437

Published: 2012

Journal Articles

A Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab As Maintenance Therapy Following R-CHOP Chemotherapy for Patients with High Risk Diffuse Large B-Cell Lymphoma

Nishitha M. Reddy, MD, Rhea M Simons, RN, Meghan E Caldwell, NP, Heidi Chen, PhD, Madan Jagasia, MBBS, MS, David S Morgan, MD, Steven I. Park, MD, John P Greer, MD, Kristy L. Richards, PhD, MD

Blood (2012) 120 (21): 3668.

https://doi.org/10.1182/blood.V120.21.3668.3668

Published: 2012

Journal Articles

Vorinostat in Combination with Pegylated Liposomal Doxorubicin (PLD) and Bortezomib (B) in Patients with Relapsed/Refractory Multiple Myeloma (R/R MM): Final Results of a Phase I Study,

Peter M. Voorhees, MD, Cristina Gasparetto, MD, Keren Osman, MD, Kristy L. Richards, PhD, MD, Madlyn Ferraro, RN, OCN, CCRC, Reynaldo Garcia, RN, Jennifer MacLean, RN, OCN, Diane Winans, CCRP, Dominic Moore, PhD, John Strader, PA-C, Robert Z. Orlowski, MD, PhD, David Duane Hurd, MD

Blood (2011) 118 (21): 3985.

https://doi.org/10.1182/blood.V118.21.3985.3985

Published: 2011

Journal Articles

The Predictive Value of FCGR3A Polymorphism on Clinical Outcomes of Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Chemotherapy

Steven I. Park, MD, Amy S. Lucas, MD, Michael Kingberg, BSc, Dominic Moore, PhD, Michael Chiu, MS, Anne M.D. Misher, BSc, Janelle Hoskins, PhD, Cherie H. Dunphy, MD, Howard L. McLeod, Pharm D, Kristy L. Richards, PhD, MD

Blood (2011) 118 (21): 89.

https://doi.org/10.1182/blood.V118.21.89.89

Published: 2011

Journal Articles

A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma

Beata Holkova, MD, Edward B. Perkins, MD, PhD, Lubomir Sokol, MD, PhD, Kristy L. Richards, PhD, MD, Samir Parekh, MD, Rebecca Elstrom, MD, Ashraf Z. Badros, MD, Igor Espinoza-Delgado, MD, Michael J. Schell, PhD, Amy Kimball, MD, PhD, Mary Beth Tombes, RN, Ellen Shrader, Heidi Sankala, PhD, Domenico Coppola, MD, Maciej Kmieciak, PhD, Daniel Sullivan, MD, John D. Roberts, MD, Steven Grant, MD

Blood (2011) 118 (21): 779.

https://doi.org/10.1182/blood.V118.21.779.779

Published: 2011

Journal Articles

Characterizing Canine Lymphoma As a Potential Large Animal Model of Human Diffuse Large B-Cell Lymphoma

Kristy L. Richards, PhD, MD, Alison Motsinger-Reif, PhD, Hsiao-Wei Chen, MS, Yuri D. Fedoriw, MD, Cheng Fan, MS, Dahlia M. Nielsen, PhD, Rachael Thomas, PhD, Chris Smith, MS, Sandeep S. Dave, MD, Charles M. Perou, PhD, Matthew Breen, PhD, Steven E. Suter, VMD, PhD

Blood (2011) 118 (21): 5193.

https://doi.org/10.1182/blood.V118.21.5193.5193

Published: 2011

Journal Articles

Whole Genome and Exome Sequencing Reveals the Genetic Landscape of Burkitt Lymphoma

Blood (2011) 118 (21): 433.

https://doi.org/10.1182/blood.V118.21.433.433

Published: 2011

Journal Articles

A Phase I, Dose Escalation Study of Clofarabine in Combination with Fractionated Gemtuzumab Ozogamicin in Relapsed and Refractory Acute Myeloid Leukemia (AML).

C Foster Matthew, MD, Chirag Amin, MD, Peter M Voorhees, MD, Hendrik W. Van Deventer, MD, Kristy L. Richards, PhD, MD, Anastasia Ivanova, Jennifer Whitman, RN, BSN, Thomas C. Shea, MD

Blood (2009) 114 (22): 2048.

https://doi.org/10.1182/blood.V114.22.2048.2048

Published: 2009

Journal Articles

A Comprehensive Identification of the Microrna Transcriptome and Its Application in B Cell Malignancies.

Blood (2009) 114 (22): 2403.

https://doi.org/10.1182/blood.V114.22.2403.2403

Published: 2009

Journal Articles

Vorinostat in Combination with Pegylated Liposomal Doxorubicin and Bortezomib for Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase I Study.

Peter M. Voorhees, MD, Cristina Gasparetto, MD, Kristy L. Richards, PhD, MD, Reynaldo Garcia, RN, OCN, John S. Strader, Madlyn Ferraro, RN, OCN, CCRC, Jennifer MacLean, RN, Diane Winans, Dominic T. Moore, PhD, Andrew Dodd, Matthew C. Foster, MD, Don A. Gabriel, MD, PhD, Thomas C. Shea, Jonathan Serody, MD, Hendrik W. van Deventer, MD, Syed Rizvi, Robert Z. Orlowski, M.D., Ph.D., David D. Hurd, MD

Blood (2009) 114 (22): 306.

https://doi.org/10.1182/blood.V114.22.306.306

Published: 2009

NARROW

Integrative Genetic and Clinical Analysis through Whole Exome Sequencing in 1001 Diffuse Large B Cell Lymphoma (DLBCL) Patients Reveals Novel Disease Drivers and Risk Groups

Targeting ß -Catenin Signaling in DLBCL with ICG-001 and PAM-1 Suppresses Cell Proliferation and Induces Apoptosis

Phase III Randomized Study of R-CHOP Versus DA-EPOCH-R and Molecular Analysis of Untreated Diffuse Large B-Cell Lymphoma: CALGB/Alliance 50303

Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab Following Standard Chemotherapy for Patients with Intermediate-High/High Risk Diffuse Large B-Cell Lymphoma (DLBCL) - Final Results

Antiretroviral Therapy Has Equalized Presentations and Short-Term Outcomes Between HIV+ and HIV- Lymphoma Patients in Lilongwe, Malawi

A Phase 2 Trial of Induction Chemotherapy with ABVD Followed By Brentuximab Vedotin Consolidation in Patients with Previously Untreated Non-Bulky Stage I or II Hodgkin Lymphoma

Investigation of the Novel Anti-Leukemia Effects of the Marine Compound Pateamine A.

A Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab As Maintenance Therapy Following R-CHOP Chemotherapy for Patients with High Risk Diffuse Large B-Cell Lymphoma

Vorinostat in Combination with Pegylated Liposomal Doxorubicin (PLD) and Bortezomib (B) in Patients with Relapsed/Refractory Multiple Myeloma (R/R MM): Final Results of a Phase I Study,

The Predictive Value of FCGR3A Polymorphism on Clinical Outcomes of Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Chemotherapy

A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma

Characterizing Canine Lymphoma As a Potential Large Animal Model of Human Diffuse Large B-Cell Lymphoma

Whole Genome and Exome Sequencing Reveals the Genetic Landscape of Burkitt Lymphoma

A Phase I, Dose Escalation Study of Clofarabine in Combination with Fractionated Gemtuzumab Ozogamicin in Relapsed and Refractory Acute Myeloid Leukemia (AML).

A Comprehensive Identification of the Microrna Transcriptome and Its Application in B Cell Malignancies.

Vorinostat in Combination with Pegylated Liposomal Doxorubicin and Bortezomib for Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase I Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only